Evidence map›Paper›PMID 20016485›Full record

ArticleNature2010

A comprehensive catalogue of somatic mutations from a human cancer genome.

Erin D Pleasance, R Keira Cheetham, Philip J Stephens, David J McBride, Sean J Humphray, Chris D Greenman, Ignacio Varela, Meng-Lay Lin, Gonzalo R Ordóñez, Graham R Bignell and 35 more

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 876 papers.

0numbers the graph read from it
0cells of the map it votes in
876citing papers in PubMed
61.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

876 citing papers in PubMed, 1,720 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Early ultraviolet exposure disrupts late dorsal fin skeletal development in zebrafish.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Mutational signatures in hematological malignancies.Einstein (Sao Paulo, Brazil) · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

816 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 5 institutions in 3 countries.

Erin D PleasanceWellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
R Keira Cheetham
Philip J Stephens
David J McBride
Sean J Humphray
Chris D Greenman
Ignacio Varela
Meng-Lay Lin
Gonzalo R Ordóñez
Graham R Bignell
Kai Ye
Julie Alipaz
Markus J Bauer
David Beare
Adam Butler
Richard J Carter
Lina Chen
Anthony J Cox
Sarah Edkins
Paula I Kokko-Gonzales
Niall A Gormley
Russell J Grocock
Christian D Haudenschild
Matthew M Hims
Terena James
Mingming Jia
Zoya Kingsbury
Catherine Leroy
John Marshall
Andrew Menzies
Laura J Mudie
Zemin Ning
Tom Royce
Ole B Schulz-Trieglaff
Anastassia Spiridou
Lucy A Stebbings
Lukasz Szajkowski
Jon Teague
David Williamson
Lynda Chin
Mark T Ross
Peter J Campbell
David R Bentley
P Andrew Futreal
Michael R Stratton
Wellcome Sanger Institute · GBIllumina (United Kingdom) · GBIllumina (United States) · USDana-Farber Cancer Institute · USLeiden University Medical Center · NL

Funding

Wellcome Trust 077012/Z/05/ZWellcome Trust 088340Wellcome Trust 093867
6 · The paper itself

Abstract

All cancers carry somatic mutations. A subset of these somatic alterations, termed driver mutations, confer selective growth advantage and are implicated in cancer development, whereas the remainder are passengers. Here we have sequenced the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The catalogue provides remarkable insights into the forces that have shaped this cancer genome. The dominant mutational signature reflects DNA damage due to ultraviolet light exposure, a known risk factor for malignant melanoma, whereas the uneven distribution of mutations across the genome, with a lower prevalence in gene footprints, indicates that DNA repair has been preferentially deployed towards transcribed regions. The results illustrate the power of a cancer genome sequence to reveal traces of the DNA damage, repair, mutation and selection processes that were operative years before the cancer became symptomatic.

Indexed as

AdultCell Line, TumorDNA DamageDNA Mutational AnalysisDNA RepairGene DosageGenes, NeoplasmGenome, HumanHumansLoss of HeterozygosityMaleMelanomaMicroRNAsMutagenesis, InsertionalMutationNeoplasmsMicroRNAs

Identifiers

PMID20016485
PMCPMC3145108
OpenAlexW2150677022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.